Michael Schomaker
Michael Schomaker
Home
Research
Software & Code
Teaching
Book
Contact
Light
Dark
Automatic
Twelve-year mortality in adults initiating antiretroviral therapy in South Africa
M. Cornell
,
L. F. Johnson
,
R. Wood
,
F. Tanser
,
M. P. Fox
,
H. Prozesky
,
M. Schomaker
,
M. Egger
,
M. A. Davies
,
A. Boulle
September 2017
PDF
Cite
Type
Journal article
Publication
Journal of the International AIDS Society
, 20(1): pp.21902
HIV
mortality
Related
A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy
Anti-V3-Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2-Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency
Cite
×